HER2-Positive Breast Cancer

This track focuses on HER2-positive breast cancer biology, diagnostic testing, and therapeutic advancements. Discussions include HER2-targeted therapies, antibody-drug conjugates, resistance mechanisms, and novel biomarkers. Participants will learn about evolving treatment algorithms and personalized therapeutic strategies. Updates from recent clinical trials will also be presented. The session highlights innovations improving survival in HER2-positive patients.

    Related Conference of HER2-Positive Breast Cancer

    July 23-24, 2026

    6th World Pathology Conference

    Amsterdam, Netherlands
    March 25-26, 2027

    25th European Pathology Congress

    Paris, France
    March 29-30, 2027

    25th Annual Pathology Congress

    Dubai, UAE

    HER2-Positive Breast Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in